1)Tavassoli FA:Mesenchymal lesions. Pathology of the Breast. East Norwalk, Conn, Appleton & Lang, 1999, pp 706-709
2)Fletcher CDM, Bridge JA, Hogendoorn PCW, et al:WHO Classification of Tumours of Soft Tissue and Bone, 4th ed. Lyon, IARC Press, 2013, pp 42-43
3)Gebhard S, Coindre JM, Michels JJ, et al:Pleomorphic liposarcoma:clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases:a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 26:601-616, 2002
4)Hornick JL, Bosenberg MW, Mentzel T, et al:Pleomorphic liposarcoma clinicopathologic analysis of 57 cases. Am J Surg Pathol 28:1257-1267, 2004
5)Ghadimi MP, Liu P, Peng T, et al:Pleomorphic liposarcoma:clinical observations and molecular variables. Cancer 117:5359-5369, 2011
6)Italiano A, Garbay D, Cioffi A, et al:Advanced pleomorphic liposarcomas:clinical outcome and impact of chemotherapy. Ann Oncol 23:2205-2206, 2012
7)Parikh BC, Ohri A, Desai MY, et al:Liposarcoma of the breast:a case report. Eur J Gynaecol Oncol 28:425-427, 2007
8)Powell CM, Rosen PP:Adipose differentiation in cystosarcoma phyllodes. A study of 14 cases. Am J Surg Pathol 18:720-727, 1994
9)柴田紘一郎,古賀保範,鬼塚敏男,他:乳腺脂肪肉腫の経験.外科診療10:1289-1292,1983
10)佐古田洋子,河野範男,寒原芳浩,他:乳腺脂肪肉腫の1例.日臨外医会誌55:2517-2521,1994
11)Dickson MA, Tap WD, Keohan ML, et al:Phase Ⅱ trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. J Clin Oncol 31:2024-2028, 2013
12)Grosso F, Jones RL, Demetri GD, et al:Efficacy of trabectedin(ecteinascidin-743)in advanced pretreated myxoid liposarcoma:a retrospective study. Lancet Oncol 8:595-602, 2007